Jing Yang

US Patent:

8013015, Sep 6, 2011

Filed:

Oct 1, 2009

Appl. No.:

12/571538

Inventors:

Patrcik G. Harran - Los Angeles CA, US
Michael S. Brown - Dallas TX, US
Joseph L. Goldstein - Dallas TX, US
Jing Yang - Dallas TX, US

Assignee:

Board of Regents, The University of Texas System - Austin TX

International Classification:

A61K 31/505
A61K 31/27
A61K 31/216
A61K 31/165
C07D 239/26
C07C 275/18
C07C 271/22
C07C 235/32

US Classification:

514489, 514256, 514595, 514588, 514516, 544335, 564 56, 564158, 564159, 560125

Abstract:

Ghrelin O-acyltransferase (GOAT) is inhibited with designed small molecules. Methods comprise contacting the GOAT with an inhibitor and detecting a resultant inhibition.

US Patent:

8329745, Dec 11, 2012

Filed:

Sep 6, 2011

Appl. No.:

13/226471

Inventors:

Patrcik G. Harran - Los Angeles CA, US
Michael S. Brown - Dallas TX, US
Joseph L. Goldstein - Dallas TX, US
Jing Yang - Dallas TX, US

Assignee:

Board of Regents, The University of Texas System - Austin TX

International Classification:

A61K 31/4164
A61K 31/505
A61K 31/27
A61K 31/216
A61K 31/165
C07D 233/60
C07D 239/26
C07C 275/18
C07C 271/22
C07C 235/32

US Classification:

514489, 514256, 514595, 514588, 514516, 514399, 544335, 564 56, 564158, 564159, 560125, 5483415

Abstract:

Ghrelin O-acyltransferase (GOAT) is inhibited with designed small molecules of the general formula:.

US Patent:

20230027890, Jan 26, 2023

Filed:

May 3, 2022

Appl. No.:

17/735869

Inventors:

- Los Angeles CA, US
Jing Yang - Los Angeles CA, US
Hanyuan Xiao - Los Angeles CA, US

Assignee:

University of Southern California - Los Angeles CA

International Classification:

G06T 15/50
G06T 15/80
G06T 15/10
G06T 15/04

Abstract:

Methods and systems are provided for rendering photo-realistic images of a subject or an object using a differentiable neural network for predicting indirect light behavior. In one example, the differentiable neural network outputs a volumetric light map comprising a plurality of spherical harmonic representations. Further, using a reflectance neural network, roughness and scattering coefficients associated with the subject or the object is computed. The volumetric light map, as well as the roughness and scattering coefficients are the utilized for rendering a final image under one or more of a desired lighting condition, desired camera view angle, and/or with a desired visual effect (e.g., expression change).

US Patent:

20200325444, Oct 15, 2020

Filed:

Jun 23, 2020

Appl. No.:

16/909908

Inventors:

- Oakland CA, US
Jing YANG - Irvine CA, US

International Classification:

C12N 5/079
A61K 9/00
A61K 35/30
C12N 5/0797

Abstract:

Disclosed herein are compositions and methods for treating, ameliorating or preventing a retinal disease or condition; improving a photopic (day light) vision; for improving correcting visual acuity, improving macular function, improving a visual field, or improving scotopic (night) vision by administration of retinal progenitor cells. The subject matter described herein also provides cell populations comprising retinal progenitor cells and methods of isolation thereof.

US Patent:

20200157498, May 21, 2020

Filed:

Jan 15, 2020

Appl. No.:

16/743930

Inventors:

- Oakland CA, US
Jing YANG - Irvine CA, US

International Classification:

C12N 5/079
C12N 5/0797
A61K 9/00
A61K 35/30

Abstract:

Disclosed herein are compositions and methods for treating, ameliorating or preventing a retinal disease or condition; improving a photopic (day light) vision; for improving correcting visual acuity, improving macular function, improving a visual field, or improving scotopic (night) vision by administration of retinal progenitor cells. The subject matter described herein also provides cell populations comprising retinal progenitor cells and methods of isolation thereof.

US Patent:

20200140811, May 7, 2020

Filed:

Jun 5, 2018

Appl. No.:

16/618919

Inventors:

- Oakland CA, US
Jing YANG - Irvine CA, US

International Classification:

C12N 5/079
A61K 35/30
A61K 9/00

Abstract:

Disclosed herein are compositions and methods for treating, ameliorating or preventing a retinal disease or condition; improving a photopic (day light) vision; for improving correcting visual acuity, improving macular function, improving a visual field, or improving scotopic (night) vision by administration of retinal progenitor cells.

US Patent:

20190085287, Mar 21, 2019

Filed:

Apr 12, 2018

Appl. No.:

15/951955

Inventors:

- Oakland CA, US
Jing YANG - Irvine CA, US

International Classification:

C12N 5/079
A61K 9/00
A61K 35/30
C12N 5/0797

Abstract:

Disclosed herein are compositions and methods for treating, ameliorating or preventing a retinal disease or condition; improving a photopic (day light) vision; for improving correcting visual acuity, improving macular function, improving a visual field, or improving scotopic (night) vision by administration of retinal progenitor cells. The subject matter described herein also provides cell populations comprising retinal progenitor cells and methods of isolation thereof.

US Patent:

20160319243, Nov 3, 2016

Filed:

May 2, 2016

Appl. No.:

15/144628

Inventors:

Henry KLASSEN - Irvine CA, US
Jing YANG - Irvine CA, US

International Classification:

C12N 5/079
A61K 9/00
A61K 35/30

Abstract:

Disclosed herein are compositions and methods for treating, ameliorating or preventing a retinal disease or condition; improving a photopic (day light) vision; for improving correcting visual acuity, improving macular function, improving a visual field, or improving scotopic (night) vision by administration of retinal progenitor cells. The subject matter described herein also provides cell populations comprising retinal progenitor cells and methods of isolation thereof.